BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19797187)

  • 1. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis.
    Bath PM; Martin RH; Palesch Y; Cotton D; Yusuf S; Sacco R; Diener HC; Toni D; Estol C; Roberts R;
    Stroke; 2009 Nov; 40(11):3541-6. PubMed ID: 19797187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.
    Bath PM; Cotton D; Martin RH; Palesch Y; Yusuf S; Sacco R; Diener HC; Estol C; Roberts R;
    Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early initiation of BP lowering with telmisartan after a stroke. PRoFESS results: addition of telmisartan 80 mg compared to placebo in ischaemic stroke.
    Cardiovasc J Afr; 2008; 19(3):166. PubMed ID: 18568184
    [No Abstract]   [Full Text] [Related]  

  • 4. Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy.
    Weber R; Weimar C; Blatchford J; Hermansson K; Wanke I; Möller-Hartmann C; Gizewski ER; Forsting M; Demchuk AM; Sacco RL; Saver JL; Warach S; Diener HC; Diehl A;
    Stroke; 2012 Sep; 43(9):2336-42. PubMed ID: 22738922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
    Diener HC; Sacco R; Yusuf S; ;
    Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in ischemic and hemorrhagic recurrence rates among race-ethnic groups in the PRoFESS secondary stroke prevention trial.
    Estol CJ; Bath PM; Gorelick PB; Cotton D; Martin RH;
    Int J Stroke; 2014 Oct; 9 Suppl A100():43-7. PubMed ID: 24636673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.
    Nakamura T; Tsutsumi Y; Shimizu Y; Uchiyama S
    J Stroke Cerebrovasc Dis; 2010; 19(6):435-40. PubMed ID: 20702114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level of systolic blood pressure within the normal range and risk of recurrent stroke.
    Ovbiagele B; Diener HC; Yusuf S; Martin RH; Cotton D; Vinisko R; Donnan GA; Bath PM;
    JAMA; 2011 Nov; 306(19):2137-44. PubMed ID: 22089721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure measurement reliability among different racial-ethnic groups in a stroke prevention study.
    Estol CJ; Bath PM; Gorelick PB; Cotton D; Martin RH; Weber MA; Dahlof B; ;
    Blood Press Monit; 2014 Oct; 19(5):256-62. PubMed ID: 24736279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing stroke: the PRoFESS, ONTARGET, and TRANSCEND trial programs.
    Diener HC
    J Hypertens Suppl; 2009 Jul; 27(5):S31-6. PubMed ID: 19587553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the GAIN International Trial.
    Aslanyan S; Fazekas F; Weir CJ; Horner S; Lees KR;
    Stroke; 2003 Oct; 34(10):2420-5. PubMed ID: 14500934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of blood pressure profiles as predictors of long-term outcome after acute ischemic stroke.
    Yong M; Diener HC; Kaste M; Mau J
    Stroke; 2005 Dec; 36(12):2619-25. PubMed ID: 16254220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan to prevent recurrent stroke and cardiovascular events.
    Yusuf S; Diener HC; Sacco RL; Cotton D; Ounpuu S; Lawton WA; Palesch Y; Martin RH; Albers GW; Bath P; Bornstein N; Chan BP; Chen ST; Cunha L; Dahlöf B; De Keyser J; Donnan GA; Estol C; Gorelick P; Gu V; Hermansson K; Hilbrich L; Kaste M; Lu C; Machnig T; Pais P; Roberts R; Skvortsova V; Teal P; Toni D; VanderMaelen C; Voigt T; Weber M; Yoon BW;
    N Engl J Med; 2008 Sep; 359(12):1225-37. PubMed ID: 18753639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between hyperacute blood pressure and outcome after ischemic stroke: data from the VISTA collaboration.
    Sare GM; Ali M; Shuaib A; Bath PM;
    Stroke; 2009 Jun; 40(6):2098-103. PubMed ID: 19359649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are ACE-inhibitors or ARB's still needed for cardiovascular prevention in high risk patients? Insights from profess and transcend.
    Van Mieghem W; Billiouw JM; Brohet C; Dupont AG; Gazagnes MD; Heller F; Krzesinski JM; Missault L; Persu A; Piérard L; Rottiers R; Vanhooren G; Vervaet P; Herman AG
    Acta Clin Belg; 2010; 65(2):107-14. PubMed ID: 20491360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consistency of blood pressure control after ischemic stroke: prevalence and prognosis.
    Towfighi A; Markovic D; Ovbiagele B
    Stroke; 2014 May; 45(5):1313-7. PubMed ID: 24676779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.
    Yong M; Diener HC; Kaste M; Mau J
    Cerebrovasc Dis; 2007; 24(4):349-54. PubMed ID: 17690547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.